236 related articles for article (PubMed ID: 33014257)
1. Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.
Akamike IC; Okedo-Alex IN; Agu AP; Alo C; Ogbonnaya LU
Pan Afr Med J; 2020; 36():261. PubMed ID: 33014257
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria.
Busari AA; Oshikoya KA; Adejumo IA; Olanrewaju OA; Usman SO; Badru WA; Oreagba IA; Olayemi SO
Pan Afr Med J; 2021; 39():123. PubMed ID: 34527139
[TBL] [Abstract][Full Text] [Related]
3. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
4. Effect of mobile-phone messaging on patient and health-worker knowledge and adherence to the isoniazid preventive therapy guideline in HIV clinics in Southeast, Nigeria.
Akamike IC; Okedo-Alex IN; Alo C; Agu AP; Uneke CJ; Ogbonnaya LU
BMC Infect Dis; 2021 Oct; 21(1):1080. PubMed ID: 34666686
[TBL] [Abstract][Full Text] [Related]
5. Health workers' knowledge and practice of Isoniazid preventive treatment guidelines in health facilities in Ebonyi State, Nigeria.
Akamike IC; Okedo-Alex IN; Uneke CJ; Madubueze UC; Agbo UN; Okeke IM; Ogbonnaya LU
Malawi Med J; 2022 Sep; 34(3):184-191. PubMed ID: 36406103
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
[TBL] [Abstract][Full Text] [Related]
7. Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.
Moolphate S; Lawpoolsri S; Pungrassami P; Sanguanwongse N; Yamada N; Kaewkungwal J
Glob J Health Sci; 2013 Mar; 5(4):60-70. PubMed ID: 23777722
[TBL] [Abstract][Full Text] [Related]
8. Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria.
Ogunsola OO; Ajayi O; Ojo O; Adeyeye O; Akinro Y; Oke O; Adurogbola AA; Olajide O
Pan Afr Med J; 2019; 34():193. PubMed ID: 32180867
[TBL] [Abstract][Full Text] [Related]
9. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
10. The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
Grande SW; Adams LV; Maseko TSB; Talbot EA; deGijsel D; Mikal J; Simelane ZZ; Achili A; Mkhontfo M; Haumba SM
PLoS One; 2020; 15(5):e0232841. PubMed ID: 32469990
[TBL] [Abstract][Full Text] [Related]
11. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
Maokola W; Ngowi B; Lawson L; Robert M; Mahande M; Todd J; Msuya S
Int J Infect Dis; 2021 Feb; 103():562-567. PubMed ID: 33276111
[TBL] [Abstract][Full Text] [Related]
12. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
[TBL] [Abstract][Full Text] [Related]
13. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.
Ayele HT; van Mourik MS; Bonten MJ
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1342-1347. PubMed ID: 27725045
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.
Mindachew M; Deribew A; Tessema F; Biadgilign S
BMC Public Health; 2011 Dec; 11():916. PubMed ID: 22151609
[TBL] [Abstract][Full Text] [Related]
15. Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.
Dhungana GP; Thekkur P; Chinnakali P; Bhatta U; Pandey B; Zhang WH
BMJ Open; 2019 May; 9(5):e029058. PubMed ID: 31147370
[TBL] [Abstract][Full Text] [Related]
16. Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi.
Thindwa D; MacPherson P; Choko AT; Khundi M; Sambakunsi R; Ngwira LG; Kalua T; Webb EL; Corbett EL
Int J Tuberc Lung Dis; 2018 Mar; 22(3):273-279. PubMed ID: 29471904
[TBL] [Abstract][Full Text] [Related]
17. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
18. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
19. High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland.
Adams LV; Mahlalela N; Talbot EA; Pasipamire M; Ginindza S; Calnan M; Haumba S
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1127-1132. PubMed ID: 28911356
[TBL] [Abstract][Full Text] [Related]
20.
Lai J; Dememew Z; Jerene D; Abashawl A; Feleke B; Teklu AM; Ruff A
Int J Tuberc Lung Dis; 2019 Mar; 23(3):371-377. PubMed ID: 30871669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
